Evidence map›Paper›PMID 39269169›Full record

ArticlemBio2024

HIV-1 Vpr-induced DNA damage activates NF-κB through ATM-NEMO independent of cell cycle arrest.

Carina Sandoval, Karly Nisson, Oliver I Fregoso

Abstract read
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The HIV-1 Vpr R77Q mutant alters host apoptotic gene regulation in CD4+ T cells.Frontiers in cellular and infection microbiology · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Carina SandovalMolecular Biology Institute, University of California, Los Angeles, California, USA.ORCID 0000-0002-4085-6810
Karly NissonMolecular Biology Institute, University of California, Los Angeles, California, USA.
Oliver I FregosoMolecular Biology Institute, University of California, Los Angeles, California, USA.ORCID 0000-0003-3087-3374

Funding

UCLA NIGMS T32 Program AssessmentT32GM007185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TORRES, JORGE · 1985 to 2020
$21.7M
MULTIDISCIPLINARY TRAINING IN MICROBIAL PATHOGENESIST32AI007323 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Peter John Bradley · 1988 to 2026
$8.6M
Defining the regulation of double-strand DNA break repair by HIV VprR01AI147837 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREGOSO, OLIVER I · 2019 to 2023
$1.9M
Characterizing Vpr-mediated Activation of the DNA Damage Response (DDR) in HIV ReplicationF31AI165286 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SANDOVAL, CARINA · 2022 to 2023
$41k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) F31AI165286HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI147837HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI007323HHS | NIH | National Institute of General Medical Sciences (NIGMS) T32GM007185NIAID NIH HHS F31 AI165286NIAID NIH HHS R01 AI147837NIAID NIH HHS T32 AI007323NIGMS NIH HHS T32 GM007185
6 · The paper itself

Abstract

Lentiviruses encode a number of multi-functional accessory proteins, however, the primary role of the accessory protein Vpr remains unclear. As Vpr engages the host DNA damage response (DDR) at multiple steps, modulation of the DDR is considered central to the function(s) of Vpr. Vpr activates ataxia telangiectasia and Rad3 (ATR)-mediated DDR signaling, resulting in cell cycle arrest. However, the cellular consequences of Vpr-induced DNA damage, and the connection of Vpr-induced DNA damage to other Vpr functions, are unknown. Here, we determined that HIV-1 Vpr-induced DNA damage activates the ATM-NF-κB essential modulator (NEMO) pathway and alters cellular transcription via NF-κB/RelA. Through RNA-sequencing (RNA-seq) of cells expressing Vpr or mutants that separate the ability of Vpr to induce DNA damage from other DDR phenotypes, we identified that Vpr alters the transcriptome independent of cell cycle arrest. In tissue-cultured U2OS cells and primary human monocyte-derived macrophages (MDMs), we showed Vpr activates both ataxia telangiectasia mutated (ATM) and NF-κB/RelA signaling cascades. While inhibition of NEMO did not affect Vpr-induced DNA damage, it prevented NF-κB activation by Vpr, highlighting the importance of NEMO in Vpr-mediated transcriptional reprogramming. Virion-delivered Vpr was sufficient to induce DNA damage and activate ATM-NEMO dependent NF-κB transcription, suggesting that engagement of the DDR and transcriptional changes can occur early during viral replication. Together, our data uncover cellular consequences of Vpr-induced DNA damage and provide a mechanism for how Vpr activates NF-κB through DNA damage and ATM-NEMO signaling, which occur independent of cell cycle arrest. We propose this is essential to overcoming restrictive environments, such as in macrophages, to enhance viral replication.IMPORTANCEThe HIV accessory protein Vpr is multi-functional and required for viral replication

Indexed as

Ataxia Telangiectasia Mutated ProteinsCell Cycle CheckpointsDNA DamageHIV-1NF-kappa Bvpr Gene Products, Human Immunodeficiency VirusHost-Pathogen InteractionsHumansI-kappa B KinaseMacrophagesSignal TransductionTranscription Factor RelAAtaxia Telangiectasia Mutated ProteinsATM protein, humanI-kappa B KinaseIKBKG protein, humanNF-kappa BTranscription Factor RelAvpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1DNA damagehost responsehuman immunodeficiency virusmacrophagesNF-kBtranscription factorsvirus-host interactionsVpr

Identifiers

PMID39269169
PMCPMC11481869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.